(+)-VINCRISTINE
Metastatic Squamous Neck Cancer With Occult Primary Squamous Cell Carcinoma
National Cancer Institute (NCI)Small moleculePhase 1/2Dormant
CCC
52/ 100
Provisional rating · Methodology v0.2
Rating breakdown
- Clinical Evidence
- 37/ 100
- Competitive Position
- 95/ 100
Competitive context
0 Active assets in the Metastatic Squamous Neck Cancer With Occult Primary Squamous Cell Carcinoma cohort.
| Asset / Sponsor | Phase | Rating |
|---|---|---|
(18F)FPPRGD2 Sanjiv Sam Gambhir | Phase 1/2 | CCC |
Cetuximab National Cancer Institute (NCI) | Phase 1/2 | CCC |
Irinotecan National Cancer Institute (NCI) | Phase 1/2 | CCC |
FLUDEOXYGLUCOSE Sanjiv Sam Gambhir | Phase 1/2 | CCC |
(11-L-THREONINE, 29-L-ARGININE)LACTOFERRIN(HUMAN) PRODUCED BY ASPERGILLUS NIGER VAR. AWAMORI Stanford University | Phase 1 | CC |
Same molecule, other indications
(+)-VINCRISTINE is also rated in:
Are you the sponsor?
Submit your data room for a Verified Rating. The public-data rating remains visible alongside.
Contact →